Renehavis Injection View larger

Renehavis syringe pre-filled with injectable hyaluronic acid

189,90 €

Renehavis syringe pre-filled with injectable hyaluronic acid. Renehavis is a one pre-filled syringe (two-chamber with 0.7ml of hyaluronic sodium LMW 22mg / ml and 0.7ml of hyaluronic sodium HMW 10mg / m) for a sequential injection. See details about, what is it for, composition of administration and its prospect at BCNPharma
Más información

5 Items

Renehavis Injection

Renehavis pre-filled syringe
Renehavis is a one pre-filled syringe (two-chamber with 0.7ml of hyaluronic sodium LMW 22mg / ml and 0.7ml of hyaluronic sodium HMW 10mg / m) for a sequential injection. See details about, what is it for, composition of administration and its prospect at BCNPharma

 
 
What is Renehavis?
Renehavis what is it for?
How is the syringe
Renehavis is manufactured by laboratory:
Check the online prospectus:
Renehavis composition:
 
It is the only product in the world that contains two hyaluronic acids in a syringe for a sequential injection.
Renehavis what is it for?
RenehaVis® is a treatment performed by two injections (over a period of two weeks) for osteoarthritis of the knee.
It must be administered by a health professional since its application is intra-articular (inside the synovial capsule of the knee).
RenehaVis® is presented in a patented double-chamber syringe containing two hyaluronic acids of different molecular weight, which are administered sequentially.

The syringe
The first chamber contains Hyaluronic Acid of low molecular weight at high concentration.
The second chamber contains Hyaluronic Acid of high molecular weight at low concentration.
This product is protected by 3 patents:
Product design.
Syringe design.
Production of 2 Hyaluronic Acids.

Studies
Clinical studies have clearly shown that RenehaVis® manages to reduce pain at rest and in a situation of weight overload, more quickly than other hyaluronic acids of low and high molecular weight.
Renehavis is manufactured by laboratory:
Check the online prospectus:
Renehavis composition: Contains a two-chamber pre-filled syringe with 0.7ml of sodium hyaluronic acid LMW 22mg / ml and 0.7ml of hyaluronic sodium HMW 10mg / ml

  • Chamber 1 >
    Sodium hyaluronate Low Molecular Weight
    (LMW): 0.7ml sterile 2.2% sodium hyaluronate
    1x106 Da molecular weight.
  • Chamber 2 >
    Sodium hyaluronate High Molecular Weight
    (HMW): 0.7ml sterile 1.0% sodium

Write a review

Renehavis syringe pre-filled with injectable hyaluronic acid

Renehavis syringe pre-filled with injectable hyaluronic acid

Renehavis syringe pre-filled with injectable hyaluronic acid. Renehavis is a one pre-filled syringe (two-chamber with 0.7ml of hyaluronic sodium LMW 22mg / ml and 0.7ml of hyaluronic sodium HMW 10mg / m) for a sequential injection. See details about, what is it for, composition of administration and its prospect at BCNPharma

Menu 2

Some content in menu 2.

Descripción

Renehavis Injection

Renehavis pre-filled syringe
Renehavis is a one pre-filled syringe (two-chamber with 0.7ml of hyaluronic sodium LMW 22mg / ml and 0.7ml of hyaluronic sodium HMW 10mg / m) for a sequential injection. See details about, what is it for, composition of administration and its prospect at BCNPharma

 
 
What is Renehavis?
Renehavis what is it for?
How is the syringe
Renehavis is manufactured by laboratory:
Check the online prospectus:
Renehavis composition:
 
It is the only product in the world that contains two hyaluronic acids in a syringe for a sequential injection.
Renehavis what is it for?
RenehaVis® is a treatment performed by two injections (over a period of two weeks) for osteoarthritis of the knee.
It must be administered by a health professional since its application is intra-articular (inside the synovial capsule of the knee).
RenehaVis® is presented in a patented double-chamber syringe containing two hyaluronic acids of different molecular weight, which are administered sequentially.

The syringe
The first chamber contains Hyaluronic Acid of low molecular weight at high concentration.
The second chamber contains Hyaluronic Acid of high molecular weight at low concentration.
This product is protected by 3 patents:
Product design.
Syringe design.
Production of 2 Hyaluronic Acids.

Studies
Clinical studies have clearly shown that RenehaVis® manages to reduce pain at rest and in a situation of weight overload, more quickly than other hyaluronic acids of low and high molecular weight.
Renehavis is manufactured by laboratory:
Check the online prospectus:
Renehavis composition: Contains a two-chamber pre-filled syringe with 0.7ml of sodium hyaluronic acid LMW 22mg / ml and 0.7ml of hyaluronic sodium HMW 10mg / ml

Composición
Consejos
Comentarios
Preguntas

Productos relacionados

Download

UP20 daysto return
See Privacy Policy
Products 100%original
Reliable and Original Products
Spain and Portugal 72H
National Shipping Conditions
International Shipping Conditions
International Shipping Conditions